Efficacy of omalizumab in the therapy of severe persistent bronchial asthma Exclusive - compliance and utilisation investigation under real-life conditions

被引：0
|
作者：
Schumann, C. [1 ]
Merk, T. [1 ]
Hundack, L. [1 ]
Stoiber, K. [1 ]
Thielen, A. [2 ]
Kroegel, C. [3 ]
Hus-Marp, J. [1 ]
机构：
[1] Univ Klin Ulm, Klin Innere Med 2, Ulm, Germany
[2] Novartis, Nurnberg, Germany
[3] Univ Klin Jena, Jena, Germany
来源：
ALLERGY | 2009年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
787
引用
收藏
页码：308 / 308
页数：1
相关论文
共 50 条
  • [1] Effectiveness of omalizumab in severe persistent asthma under real-life conditions
    D'Urzo, Anthony D.
    Wong, Jenny
    CANADIAN FAMILY PHYSICIAN, 2014, 60 (07) : 643 - 645
  • [2] The real-life clinical effects of 52 weeks of omalizumab therapy for severe persistent allergic asthma
    Gouder, Caroline
    West, Lorna Marie
    Montefort, Stephen
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2015, 37 (01) : 36 - 43
  • [3] The real-life clinical effects of 52 weeks of omalizumab therapy for severe persistent allergic asthma
    Caroline Gouder
    Lorna Marie West
    Stephen Montefort
    International Journal of Clinical Pharmacy, 2015, 37 : 36 - 43
  • [4] Omalizumab in patients with severe persistent allergic asthma in a real-life setting in Germany
    Korn, S.
    Thielen, A.
    Seyfried, S.
    Taube, C.
    Kornmann, O.
    Buhl, R.
    RESPIRATORY MEDICINE, 2009, 103 (11) : 1725 - 1731
  • [5] Real-life efficacy and safety of omalizumab in Portuguese patients with persistent uncontrolled asthma
    Pereira Barbosa, M.
    Bugalho de Almeida, A.
    Pereira, C.
    Chen, C. -W.
    Georgiou, P.
    Peachey, G.
    REVISTA PORTUGUESA DE PNEUMOLOGIA, 2015, 21 (03) : 151 - 156
  • [6] Cost-effectiveness of omalizumab in severe persistent asthma in Spain: a real-life perspective
    Levy, Alberto Nahon
    Ruiz, Antonio J. Garcia A.
    Soler, Nuria Garcia-Agua
    Sanjuan, Maria Victoria Hidalgo
    JOURNAL OF ASTHMA, 2015, 52 (02) : 205 - 210
  • [7] "Real-life" effectiveness of omalizumab in patients with severe persistent allergic asthma: The PERSIST study
    Brusselle, G.
    Michils, A.
    Louis, R.
    Dupont, L.
    de Maele, B. Van
    Delobbe, A.
    Pilette, C.
    Lee, C. S.
    Gurdain, S.
    Vancayzeele, S.
    Lecomte, P.
    Hermans, C.
    MacDonald, K.
    Song, M.
    Abraham, I.
    RESPIRATORY MEDICINE, 2009, 103 (11) : 1633 - 1642
  • [8] REAL-LIFE EXPERIENCE OF OMALIZUMAB IN CHILDREN WITH SEVERE ASTHMA
    Koo, M. K.
    Bossley, C. B.
    Carlton, A. C.
    Bush, A. B.
    Saglani, S. S.
    Fleming, L. F.
    THORAX, 2013, 68 : A115 - A115
  • [9] The 'real-life' long-term efficacy of omalizumab in severe persistent IgE-mediated allergic asthma in Malta
    Gouder, Caroline
    Asciak, Rachelle
    Montefort, Stephen
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [10] Omalizumab decreases medical resource utilisation in patients with severe allergic asthma in an Italian real-life setting
    Canonica, Giorgio Walter
    Pitotti, Claudia
    Saccheri, Fabiana
    Rigoni, Laura
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50
12345